Welltower price target raised to $195 from $175 at Raymond James

Raymond James raised the firm’s price target on Welltower (WELL) to $195 from $175 and keeps a Strong Buy rating on the shares. The recession-resilient and defensive, needs-driven nature of healthcare is increasingly top of mind in the current uncertain environment, the analyst tells investors in a research note. The firm remains enamored with Welltower management’s strong operational and capital allocation acumen and believe they will continue to deliver.